Name: An in vivo Assay to Test Blood Vessel Permeability (Video) | JoVE Journal
Uploaded: 2013-03-16T13:00:00.000+00:00
Duration: 7 min 3 s
Description: Learn an in vivo assay to test blood vessel permeability using Evans blue dye in mice. This method visualizes endothelial barrier integrity and helps researchers study vascular dysfunction in pathological conditions.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by a grant from the National Institutes of Health, R01CA142928.

1. Intravenous Injection of Evans Blue in the Mouse Lateral Tail Vein
	<ol>
	 <li>Prepare a 0.5% sterile solution of Evans blue in PBS. If necessary, filter-sterilize the solution to remove any particulate matter that has not dissolved.	 </li>
 <li>Aspirate 200 &mu;l Evans Blue solution into a syringe. Avoid all air bubbles that might have escaped into the syringe. </li>
 <li>Place mice that are 8-12 weeks old into a restraint device so that the animal is not freely mobile but its tail can be handled. </li>
 <li>Place the mouse restraint device on its side so the lateral tail vein is easily visible and are facing upward. </li>
 <li>Hold onto the tail with the non-dominant hand between the thumb and the forefinger.</li>
 <li>Insert the needle (small gauge, 27-30) at a 10-15 degree angle, bevel up, advance into the lateral tail vein towards the direction of the head. Keep the needle and syringe parallel to the tail. </li>
 <li>Do not apply back pressure to confirm proper placement as this might collapse the vein. </li>
 <li>Slowly inject 200 &mu;l Evans Blue solution in the tail vein of the mouse. </li>
 <li>Observe the ease with which the plunger advances, as this is the proof of correct placement of the needle in the vein. </li>
 <li>Put the mouse back into its cage and observe it for 30 min. </li>
</ol>
2. Organ Collection and Extraction of Evans Blue from the Organs
	<ol>
	 <li>Sacrifice the mice through cervical dislocation. For Miles assay purposes cervical dislocation is recommended as it limits significant interference with vascular permeability. Sacrifice all the mice at the same time, as fast as possible. Work with cohorts of 6 mice or less, because shortly after death blood vessels become more permeable.	 </li>
 <li>Place the mice on their backs and pin their feet on a white board.</li>
 <li>Open the abdominal and thoracic cavity to expose thoracic and abdominal organs. </li>
 <li>Take representative pictures to show differences in Evans Blue extravasation. Include all mice in the same field in order to have identical lighting conditions for all mice. </li>
 <li>Collect organs of interest and put them in 1.5 ml tubes.</li>
 <li>Weigh an empty tube and bring the balance value to zero.</li>
 <li>Transfer the tissue sample and weight it. Repeat for all tissue samples. Tissues can be air dried to eliminate the water content variability between different organs.</li>
 <li>. Add 500 &mu;l formamide to each tissue sample tube. </li>
 <li>Transfer all tubes to a 55 &deg;C water bath or heat block. Incubate for 24-48 hr to extract Evans Blue from tissue. </li>
</ol>
3. Quantification of Evans Blue Extravasated in Interstitial Tissue 
	<ol>
	 <li>Centrifuge the Formamide/Evans Blue mixture to pellet any remaining tissue fragments.	 </li>
 <li>Measure absorbance at 610 nm. Use 500 &mu;l Formamide as blank. </li>
 <li>Calculate ng Evans Blue extravasated per mg tissue. </li>
 <li>Plot all data in a graph. </li>
 <li>Perform statistical analysis to determine significant differences. </li>
</ol>

<ol><li>Beck, K. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Inducible+NO+synthase%3A+role+in+cellular+signaling%5BTitle%5D)+AND+%22J.+Exp.+Biol%22%5BJournal%5D)">Inducible NO synthase: role in cellular signaling.</a> J. Exp. Biol. 202, 645-653 (1999).</li>
<li>Bertglia, S., Giusti, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+nitric+oxide+in+capillary+perfusion+and+oxygen+delivery+regulation+during+systemic+hypoxia%5BTitle%5D)+AND+%22Am.+J.+Physiol.+Heart+Circ.+Physiol%22%5BJournal%5D)">Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia.</a> Am. J. Physiol. Heart Circ. Physiol. 288, H525-H531 (2005).</li>
<li>Miles, A. A., Miles, E. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+reactions+to+histamine%2C+histamine-liberator+and+leutaxine+in+the+skin+of+guinea+pigs%5BTitle%5D)+AND+%22J.+Physiol.+%28London%29%22%5BJournal%5D)">Vascular reactions to histamine, histamine-liberator and leutaxine in the skin of guinea pigs.</a> J. Physiol. (London). 118, 228-257 (1952).</li>
<li>Weis, S. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+permeability+in+cardiovascular+disease+and+cancer%5BTitle%5D)+AND+%22Curr.+Opin.+Hematol%22%5BJournal%5D)">Vascular permeability in cardiovascular disease and cancer.</a> Curr. Opin. Hematol. 15, 243-249 (2008).</li>
<li>Kumar, P., Shen, Q., Pivetii, C. D., Lee, E. S., We, M. H., Yuan, S. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+mechanisms+of+endothelial+hyperpermeability%3A+implications+in+inflammation%5BTitle%5D)+AND+%22Expert+Rev.+Mol.+Med%22%5BJournal%5D)">Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.</a> Expert Rev. Mol. Med. 30, 11-19 (2009).</li>
<li>Viazzi, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+permeability%2C+blood+pressure%2C+and+organ+damage+in+primary+hypertension%5BTitle%5D)+AND+%22Hypertens.+Res%22%5BJournal%5D)">Vascular permeability, blood pressure, and organ damage in primary hypertension.</a> Hypertens. Res. 31, 873-879 (2008).</li>
<li>Scheppke,, et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Retinal+vascular+permeability+suppression+by+topical+application+of+a+novel+VEGFR2%2FSrc+kinase+inhibitor+in+mice+and+rabbits%5BTitle%5D)+AND+%22J.+Clin.+Invest%22%5BJournal%5D)">Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.</a> J. Clin. Invest. 118, 2337-2346 (2008).</li>
<li>Blanchet, M. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Loss+of+CD34+Leads+To+Exacerbated+Autoimmune+Arthritis+through+Increased+Vascular+Permeability%5BTitle%5D)+AND+%22J.+Immunol%22%5BJournal%5D)">Loss of CD34 Leads To Exacerbated Autoimmune Arthritis through Increased Vascular Permeability.</a> J. Immunol. 184, 1292-1299 (2010).</li>
<li>Dvorak, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mast+cell-derived+mediators+of+enhanced+microvascular+permeability%2C+vascular+permeability+factor%2Fvascular+endothelial+growth+factor%2C+histamine%2C+and+serotonin%2C+cause+leakage+of+macromolecules+through+a+new+endothelial+cell+permeability+organelle%2C+the+vesiculo-vacuolar+organelle%5BTitle%5D)+AND+%22Chem.+Immunol.+Allergy%22%5BJournal%5D)">Mast cell-derived mediators of enhanced microvascular permeability, vascular permeability factor/vascular endothelial growth factor, histamine, and serotonin, cause leakage of macromolecules through a new endothelial cell permeability organelle, the vesiculo-vacuolar organelle.</a> Chem. Immunol. Allergy. 85, 185-204 (2005).</li>
<li>Le Guelte, A., Gavard, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+endothelial+cell-cell+junctions+in+endothelial+permeability%5BTitle%5D)+AND+%22Methods+Mol.+Biol%22%5BJournal%5D)">Role of endothelial cell-cell junctions in endothelial permeability.</a> Methods Mol. Biol. 763, 265-279 (2011).</li>
<li>Martins-Green, M., Petreaca, M., Yao, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((An+assay+system+for+in+vitro+detection+of+permeability+in+human+%22endothelium%22%5BTitle%5D)+AND+%22Methods+Enzymol%22%5BJournal%5D)">An assay system for in vitro detection of permeability in human "endothelium".</a> Methods Enzymol. 443, 137-153 (2008).</li>
</ol>

The authors have no conflict or competing financial interests.

Vascular permeability is a critical marker for blood vessel status. Increased vascular permeability has been shown to be present in several systemic diseases, including diabetes, hypertension, and autoimmune diseases 6,7,8. Increased vascular permeability has been shown to be mediated by shear stress, growth factors like vascular endothelial growth factor and fibroblast growth factor, inflammatory mediators like serotonin, histamine and bradykinin 9. Extravasation of water and small molecules is tho...

Formation and maintenance of selective permeable barriers are essential for proper organ development and performance 1,2. Endothelial cells line the blood vessel lumen and form a semi-permeable barrier that is essential in the selective transport between blood and the interstitial space of all organs. An adequate permeability barrier is maintained through tight cell-to-cell junctions that are strictly controlled by growth factors, cytokines and other stress related molecules 3. Disruption of the endothelial cell barrier can result in increased permeability and vascular leakage. These effects are seen in various disease states and the understanding of the underlining molecular signaling requires multidisciplinary methods 4,5. In this article, we describe an in vivo method to measure vessel permeability using a mouse model.
The assay we are describing, also known as Miles assay, is a well-established method to test vascular permeability in vivo. The assay is based on the fact that, under basal physiological conditions, albumin does not cross the endothelial barrier. Evans Blue, an azo dye with high affinity for albumin, is injected in the blood stream of an experimental animal, and under physiologic conditions, it is expected to be restricted within blood vessels. When a vascular permeability stimulus is added, either topically or systemically, blood vessels start to leak protein and thus, also the Evans blue that is bound to albumin. This results in a rapid bluish coloration of tissues that have permeable vessels.
Successful injection of the dye in the mouse lateral tail vein is critical for the good outcome of the experiment. Tail vein injection technique requires extensive practice and should be mastered prior to starting the experiment.
 Vessel permeability is highly dependent on the age and weight of the animal, so when comparing different mouse strains it is imperative that the mice or other test subjects have close to identical birth dates and weight. Other factors that influence the permeability of the endothelial barrier are environmental conditions such as temperature, humidity, and very importantly, the handling stress of the mouse. Due to the multitude of factors that can influence the outcome of the experiment it is always advisable that the experiment is repeated at least three times and statistical analysis performed. 
This assay can be used or to compare vessel permeability of mice that have been genetically modified, as well as mice with different genetic backgrounds. Permeability can be assessed in the presence or absence of a stimulus, depending on the function of the gene that is modulated. This assay can also be used or to test the effect of different compounds on vessel permeability.

<table><tbody><tr><td colspan="4">&lt;strong&gt;REAGENT&lt;/strong&gt;</td></tr><tr><td>EVANS BLUE</td><td>SIGMA</td><td>E2129</td><td></td></tr><tr><td>FORMAMIDE</td><td>INVITROGEN</td><td>15515-026</td><td></td></tr><tr><td>PBS</td><td></td><td></td><td>0.2M Phosphate&lt;br/&gt; 1.5M NaCl&lt;br/&gt; pH 7.4</td></tr><tr><td colspan="4">&lt;strong&gt;EQUIPMENT&lt;/strong&gt;</td></tr><tr><td>SPECTROPHOTOMETER</td><td>EPPENDORF</td><td>952000006</td><td></td></tr><tr><td>MOUSE RESTRAINT DEVICE</td><td>HARVARD APPARATUS</td><td>340012</td><td></td></tr><tr><td>SYRINGE</td><td>BD</td><td>309659</td><td></td></tr><tr><td>NEEDLES</td><td>BD</td><td>305106</td><td>The gauge of the needle depends on the size of the animal.</td></tr><tr><td>BALANCE</td><td>DENVER INSTRUMENT</td><td>TP-64</td><td></td></tr></tbody></table>

an in vivo assay to test blood vessel permeability

An in vivo Assay to Test Blood Vessel Permeability

This method is based on the intravenous injection of Evans Blue in mice as the test animal model. Evans blue is a dye that binds albumin. Under physiologic conditions the endothelium is impermeable to albumin, so Evans blue bound albumin remains restricted within blood vessels. In pathologic conditions that promote increased vascular permeability endothelial cells partially lose their close contacts and the endothelium becomes permeable to small proteins such as albumin. This condition allows for extravasation of Evans Blue in tissues. A healthy endothelium prevents extravasation of the dye in the neighboring vascularized tissues. Organs with increased permeability will show significantly increased blue coloration compared to organs with intact endothelium. The level of vascular permeability can be assessed by simple visualization or by quantitative measurement of the dye incorporated per milligram of tissue of control versus experimental animal/tissue. Two powerful aspects of this assay are its simplicity and quantitative characteristics. Evans Blue dye can be extracted from tissues by incubating a specific amount of tissue in formamide. Evans Blue absorbance maximum is at 620 nm and absorbance minimum is at 740 nm. By using a standard curve for Evans Blue, optical density measurements can be converted into milligram dye captured per milligram of tissue. Statistical analysis should be used to assess significant differences in vascular permeability.

We used an in vivo permeability assay to test vessel leakage in mice 8-12 weeks old. This test is useful in comparing the relative vascular permeability between animals of different genetic background or in a single strain of mice subjected to treatments that affect the vasculature. Our results show that a strain of genetically modified mice we created in our lab has a more permeable endothelium compared to wild-type mice. These changes are evident at macroscopic level in many organs (Figure 1)...

We are presenting an in vivo assay to test blood vessel permeability. This assay is based on intravenous injection of a dye and subsequent visualization of its diffusion into interstitial spaces.

This method is based on the intravenous injection of Evans Blue in mice as the test animal model. Evans blue is a dye that binds albumin. Under ...

This video presents an in vivo assay to test blood vessel permeability. In mice, endothelial cells line the blood vessels and form a semi-permeable barrier. In physiologic conditions, endothelium is impermeable to most proteins so that they are restricted to the blood flow.In pathologic conditions that promote increased vascular permeability, endothelial cells partially lose contact to each other. Endothelium becomes permeable to small proteins such as albumin. In this assay, we inject intravenously a blue dye that binds to albumin in conditions of increased endothelial permeability.The D crosses the endothelial barrier and diffuses into the interstitial space. This ultimately results in a bluish coloration of the affected tissue before the experiment is started. Prepare all required materials, pipe it and sterile tips.Evans blue, sterile spatula, sterile PBS, sterile syringe and needles. Mice, mouse restrainer dissection instruments, dissection board and pins. Balance form ide, heat block for water bath at 55 Celsius degree.C.Vet spectrophotometer weight Evans blue powder and transfer it to a sterile tube. Add sterile PBS to obtain a 0.5%working concentration. Slowly aspirate 200 microliters Evan Blue solution into the syringe.Avoid all air bubbles and eliminate any air bubble that escaped in the syringe. Place mouse in a restraint device so that the animal is not really mobile, but its tail can be handled. Place the restraint device on its side, so the lateral tail vein is easily visible and facing upward.Hold onto the tail with a non-dominant hand between the thumb and the forefinger. Apply pressure at the base of the tail so it works as a tourniquet. Insert the needle at 10 degree angle.Bevel up and advance into the vein. Keep the needle and the syringe parallel to the tail. Do not apply back pressure to confirm proper placement of the needle in the vein.As this might collapse the vein slowly inject 200 microliters Evan Blue solution into the tail. Observe the ease with which the plunger advances as this is the proof of correct placement in the vein. If the needle is correctly placed, a small drop of blood appears after removing the needle.Apply pressure at ejected site until the bleeding stops. Put the mouse back into the cage and observe it for 30 minutes. Sacrifice the mouse and pin it to a whiteboard.We are presenting in this video both a controlled mouse and the mouse that was genetically engineered to lack a gene that controls endothelial integrity. Open the abdominal and thoracic cavity to expose the organs, collect organs of interest and put them in eend DPH tubes. Before this discarding the mouse carcass.Make sure you have representative pictures of all organs of interest. Label a new set of tubes, weight an empty tube. Bring the balance value to zero, then transfer the tissue sample to the tube and weight it.Repeat for all samples. Add 500 microliters for mite to each tube. Transfer all tubes to a 55 Celsius heat block or water bath.Incubate for 24 to 48 hours to extract Evans blue from all the tissue measure absorbance at 600 nanometer wavelength. Use 500 microliters for IDE as blank. Measure optical density for each sample.Significant differences in vascular permeability can be easily observed at this step. Calculate nanograms. Evan Blue Extravasated per milligram tissue.Plot all data in a graph the method they presented, also known as M assay, is used to test vessel permeability in mice before the experiment is started. Tail vein injections should be mastered as this technique requires extensive practice. The results should be recorded as both still pictures and quantitative measurements, and should always be accompanied by molecular analysis.Vessel permeability is highly dependent on the age and weight of the animal in addition to environmental conditions. Therefore, the experiment should be repeated at least three times and statistical analysis performed.

an-in-vivo-assay-to-test-blood-vessel-permeability

Research

JoVE Journal

Medicine

This video describes a permeability assay to evaluate the permeability of in vitro blood-brain barrier using sodium fluorescein molecules.

Blood-Brain Barrier Mimic Permeability Assay: An In Vitro Assay to Assess the Permeability of BBB Mimic to Tracer Molecules

We present a protocol to study human endothelial-pericyte interactions in mouse using a variation of the matrix gel plug angiogenesis assay.

In Vivo Study of Human Endothelial-Pericyte Interaction Using the Matrix Gel Plug Assay in Mouse

Maintaining blood-brain barrier coverage is key for the homeostasis of the central nervous system. This protocol describes in vitro techniques to delineate the fundamental and pathological processes that modulate blood-brain barrier coverage.

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Two methods are presented here to determine intestinal barrier function. An epithelial meter (volt/ohm) is used for measurements of transepithelial electrical resistance of cultured epithelia directly in tissue culture wells. In mice, the FITC-dextran gavage method is used to determine the intestinal permeability in vivo.

In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability

Here we present a mouse brain vascular permeability assay using intraperitoneal injection of fluorescent tracers followed by perfusion that is applicable to animal models of blood-brain barrier dysfunction. One hemi-brain is used for assessing permeability quantitatively and the other for tracer visualization/immunostaining. The procedure takes 5 - 6 h for 10 mice.

An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers

Here, we present a protocol to measure the vascular leakage induced by intradermal administration of permeability promoting agents into the murine skin. This technique can be used to determine the ability of molecules to promote or inhibit vascular leakage or to study the molecular mechanisms that regulate vascular permeability.

Evaluating Vascular Hyperpermeability-inducing Agents in the Skin with the Miles Assay

The access of nutrients, microbiota metabolites and medicines to the circulation is controlled by the gut-blood barrier (GBB). We describe a direct method for measuring the GBB permeability in vivo, which, in contrast to commonly used indirect methods, is virtually not affected by liver and kidney functions.

An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

We describe two methods for assessing transient vascular permeability associated with tumor microenvironment of metastasis (TMEM) doorway function and cancer cell intravasation using intravenous injection of high-molecular weight (155 kDa) dextran in mice. The methods include intravital imaging in live animals and fixed tissue analysis using immunofluorescence.

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis

This protocol illustrates an in vitro endothelial cell transcytosis assay as a model to evaluate inner blood-retinal barrier permeability by measuring the ability of human retinal microvascular endothelial cells to transport horseradish peroxidase across cells in caveolae-mediated transcellular transport processes.

Endothelial Cell Transcytosis Assay as an In Vitro Model to Evaluate Inner Blood-Retinal Barrier Permeability

In the present protocol, the endothelial barrier function of the submandibular gland (SMG) was evaluated by injecting different molecular weighted fluorescent tracers into the angular veins of test animal models in vivo under a two-photon laser-scanning microscope.

In Vivo Vascular Permeability Detection in Mouse Submandibular Gland

The method presented here can evaluate the effect of reagents on angiogenesis or vascular permeability in vivo without staining. The method uses dextran-FITC injection via the tail vein to visualize neo-vessels or vascular leakage.

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Learn an in vivo assay to test blood vessel permeability using Evans blue dye in mice. This method visualizes endothelial barrier integrity and helps researchers study vascular dysfunction in pathological conditions.

An in vivo Assay to Test Blood Vessel Permeability

Explore More Videos